APOTEX TECHNOLOGIES INC.
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Aug 31, 2017 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 175 Total Citation Count
- Feb 21, 1997 Earliest Filing
- 27 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0056,341 Extended Release Dosage Form Comprising Cyclobenzaprine HydrochlorideFeb 22, 16Mar 02, 17[A61J, A61K]
2017/0056,342 Extended Release Dosage Form Comprising Cyclobenzaprine HydrochlorideAug 31, 15Mar 02, 17[A61J, A61K]
2017/0056,343 Extended Release Dosage Form Comprising Cyclobenzaprine HydrochlorideJul 14, 16Mar 02, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8735602 Pharmaceutically acceptable salts of thymodepressin and processes for their manufactureMar 19, 12May 27, 14[C07D]
8207217 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanFeb 11, 08Jun 26, 12[A61K, C07D]
8138221 Pharmaceutically acceptable salts of thymodepressin and processes for their manufactureDec 13, 07Mar 20, 12[A61K, C07D]
8119606 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophanNov 26, 07Feb 21, 12[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0225,341 PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PROCESSES FOR THEIR MANUFACTUREAbandonedFeb 10, 14Aug 13, 15[C07D]
2015/0011,484 PRODRUGS OF D-GAMMA-GLUTAMYL-D-TRYPTOPHAN AND D-GAMMA-GLUTAMYL-L-TRYPTOPHANAbandonedMar 30, 12Jan 08, 15[C07K]
8664262 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanExpiredJun 07, 12Mar 04, 14[A61K, C07D]
8592607 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanExpiredJun 07, 12Nov 26, 13[C07D]
8507449 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophanExpiredFeb 20, 12Aug 13, 13[A61K, C07K]
8481588 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophanExpiredJun 07, 12Jul 09, 13[A61K, C07D]
8476235 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophanExpiredFeb 20, 12Jul 02, 13[A61K]
2013/0023,569 Use of Deferiprone for Treatment and Prevention of Iron-Related Eye DisordersAbandonedNov 12, 09Jan 24, 13[A61K, A61P]
2012/0157,387 ORALLY BIOAVAILABLE D-GAMMA-GLUTAMYL-D-TRYPTOPHANAbandonedFeb 20, 12Jun 21, 12[A61K, A61P, C07K]
2011/0240,504 METHOD AND APPARATUS FOR PACKAGING AND DISPENSING PHARMACEUTICALSAbandonedDec 03, 09Oct 06, 11[A61K, B65D, B65B]
2006/0183,890 Isopropanolate of azithromycin and method of manufacturingAbandonedMar 19, 04Aug 17, 06[A61K, C07H]
RE39087 Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereofExpiredJun 05, 03May 02, 06[A61K]
6476229 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamideExpiredMar 19, 02Nov 05, 02[C07D]
6472532 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-OXO-1,4-dihydropyridine-2-carboxamideExpiredMar 19, 02Oct 29, 02[C07D]
6468977 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymesExpiredMay 23, 00Oct 22, 02[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
